证券代码：688321 证券简称：微芯生物公告编号：2026-012 深圳微芯生物科技股份有限公司 关于向特定对象发行A股股票发行情况报告书披露的提示性公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 深圳微芯生物科技股份有限公司（以下简称"公司"）向特定对象发行A股股票（以下简称"本次发行"） 发行承销总结及相关文件已经上海证券交易所备案通过，公司将依据相关规定尽快办理本次发行新增股 份的登记托管事宜。 《深圳微芯生物科技股份有限公司向特定对象发行A股股票发行情况报告书》及相关文件已于同日在上 海证券交易所网站（www.sse.com.cn）披露，敬请广大投资者查阅。 特此公告。 深圳微芯生物科技股份有限公司董事会 2026年2月26日 证券代码：688321 证券简称：微芯生物 公告编号：2026-013 深圳微芯生物科技股份有限公司 关于签订募集资金专户存储三方监管协议的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 一 ...

Core Viewpoint - Chuanhuan Technology (300547.SZ) plans to issue A-shares to specific investors, aiming to raise up to 1 billion yuan for its projects and working capital [1] Group 1: Issuance Details - The company intends to issue shares to no more than 35 specific investors [1] - The issuance price will be no less than 80% of the average trading price of the company's shares over the 20 trading days prior to the pricing benchmark [1] - The total number of shares to be issued will not exceed 54,226,543 shares [1] Group 2: Fund Utilization - The total funds raised will be used for the Chuanhuan Technology (East China) Intelligent Manufacturing Headquarters Project (Phase I) and to supplement working capital [1]

Core Viewpoint - Fujian Zhangzhou Development Co., Ltd. has approved a proposal to issue A-shares to specific investors, including its controlling shareholder, Fujian Zhanglong Group Co., Ltd., as part of a capital raising strategy to support various projects [1][2][3]. Group 1: Meeting Resolutions - The first temporary meeting of the eighth supervisory board confirmed that the company meets the conditions for issuing A-shares to specific investors, with a unanimous vote of 5 in favor [1]. - The proposal for the specific A-share issuance plan was approved, with 3 votes in favor, and the controlling shareholder will participate in the subscription [2]. - The issuance will target up to 35 specific investors, including institutional and individual investors, with the controlling shareholder committing to subscribe for at least 20% of the total shares issued [3]. Group 2: Issuance Details - The shares will be RMB ordinary shares with a par value of RMB 1.00 each, and the issuance will occur after approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission [2][4]. - The pricing for the shares will not be lower than 80% of the average trading price over the 20 trading days prior to the pricing date [4]. - The total number of shares to be issued will not exceed 30% of the company's total share capital, which is currently 991,481,071 shares, translating to a maximum of 297,444,321 shares [5][9]. Group 3: Fund Utilization - The total amount to be raised from this issuance is capped at 1,050 million RMB, with net proceeds allocated to specific projects, including ecological restoration and photovoltaic power generation [8][9]. - If the actual net proceeds are less than the planned amount, the company will adjust the investment priorities based on actual funding needs [9]. - The company will initially fund projects with its own resources until the proceeds from the issuance are available [9]. Group 4: Regulatory Compliance - All proposals related to the issuance must be submitted for approval at the shareholders' meeting and require regulatory approval from the Shenzhen Stock Exchange and the China Securities Regulatory Commission [10][11]. - The company has committed to adhere to the latest regulations regarding the issuance and any associated restrictions on share transfer [6][8].

Group 1 - Huaneng Lancang River Hydropower Co., Ltd. has completed the issuance of the 2025 fifth phase of technology innovation bonds and the eighth phase of green short-term financing bonds (rural revitalization) with issuance amounts of RMB 1 billion and RMB 1.5 billion respectively [2] - The issuance rates for the technology innovation bonds and green short-term financing bonds are 1.63% and 1.65% respectively, with maturities of 184 days and 108 days [2] - After this issuance, the company's balance of short-term financing bonds (including super short-term financing bonds) is RMB 5.5 billion, and the balance of medium-term notes (including perpetual medium-term notes) is RMB 18 billion [2] Group 2 - The company received approval from the China Securities Regulatory Commission for the registration of stock issuance to specific objects, which is valid for 12 months from the date of approval [6] - The company is required to strictly implement the issuance according to the submitted documents and issuance plan to the Shanghai Stock Exchange [6] - The company must report any significant events to the Shanghai Stock Exchange before the completion of the issuance [6]